International projects
Petrovax Pharm aims at building up its international partnership and export potential. To implement its innovative strategy, the company cooperates with leading research institutes, Russian and international partners for the development of new products, technology transfer, and full-cycle manufacturing localization. Petrovax Pharm has adequate experience in implementing international projects associated with full-cycle manufacturing technology transfer as well as immunobiologicals quality control, and quality assurance.

International projects


2008

In partnership with Abbott (former Solvay Pharma), Petrovax Pharm successfully completed the construction of an up-to-date pharmaceutical complex to develop and manufacture immunobiological products in Moscow region.


2011

Petrovax Pharm, jointly with Pfizer, delivered a localization project to implement a full-cycle manufacturing, quality control, and quality assurance technology for a 13-valent pneumococcal conjugate vaccine.

Since 2014, this vaccine has been procured for the Russian national Immunization Schedule.


2015

Petrovax Pharm implemented the first in the Russian history localization project to manufacture Russian original influenza vaccine Grippol® plus in Belarus under agreement with the Ministry of Health of Belarus, and RUE Belmedpreparaty.


2016

Petrovax Pharm established a partnership with Boehringer Ingelheim to localize full-cycle manufacturing of the most advanced cardiovascular pharmaceuticals, and provide local products for the Russian public health.


2016

Petrovax Pharm made a three-party agreement to localize Grippol® plus vaccine manufacture in Iran with Sobhan Recombinant Protein, and Arvin LTD (both Iran).